Delivery Order SPE2DR25D1106-SPE2DR26FJF3S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Methylphenidate ER(LA) 40mg in quantities of 100 capsules, with a ceiling value of $1,688.65. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, executed without a set-aside designation through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules (100-count unit). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, valued at $3,375.52 and scheduled for completion by June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules, with a ceiling value of $5,698.56. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules. This is a firm fixed-price delivery order with a ceiling value of $2,359.18 and an ultimate completion date of October 23, 2025. The contract was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 10mg capsules in a quantity of 100 units, with a ceiling value of $1,020.66. This is a firm fixed price delivery order with an ultimate completion date of October 23, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules, with a ceiling value of $3,744.00 and an ultimate completion date of December 23, 2025. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER(LA) 30mg in quantities of 100 capsules. This is a firm fixed-price delivery order valued at $1,354.36, with a completion date of October 23, 2025. The award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $1,611.96 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg capsules (100 count) under a firm fixed price contract type. The award was issued on November 5, 2025, with an ultimate completion date of November 6, 2025. The contract involves no set-aside designation and represents a competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $3,226.75 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Methylphenidate ER(LA) 40mg in quantities of 100 capsules. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures, with an ultimate completion date of November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,846.82 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER(LA) 20mg capsules (100-count package). This competitive award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF3SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Methylphenidate ER(LA) 10mg in quantities of 100 capsules, valued at $1,137.56. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. The order is scheduled for completion by December 30, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this IDC framework, AmerisourceBergen fulfills critical medical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, leveraging its position as a major pharmaceutical distributor with extensive capability in delivering both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/28/25 |